Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599248 · ClinicalTrials.gov registry record · Phase 1
Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee
A Phase 1 study, sponsored by Kolon TissueGene.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00599248 is a Phase 1 study that has completed, run by Kolon TissueGene. The registered enrollment target is 12 participants.
The verdict
NCT00599248, a Phase 1 study, has completed, sponsored by Kolon TissueGene.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The study is being conducted to investigate the safety and activity of TissueGene-C injected into the knee joint of patients with chronic degenerative joint disease (DJD) who will be undergoing total knee replacement.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL TissueGene-C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599248
The ClinicalTrials.gov registry entry for NCT00599248 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kolon TissueGene, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00599248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00599248 about?
NCT00599248 is a clinical study titled "Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee". The study is being conducted to investigate the safety and activity of TissueGene-C injected into the knee joint of patients with chronic degenerative joint disease (DJD) who will be undergoing total knee replacement.
What is the current status of trial NCT00599248?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2007-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00599248?
The interventions under investigation include: Placebo (BIOLOGICAL), TissueGene-C (BIOLOGICAL).
Who is sponsoring clinical trial NCT00599248?
This trial is sponsored by Kolon TissueGene, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.